GlaxoSmithKline Pharmaceuticals Limited

BSE:500660 Stock Report

Market Cap: ₹387.0b

GlaxoSmithKline Pharmaceuticals Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Bhushan Akshikar

Chief executive officer

₹66.9m

Total compensation

CEO salary percentage21.7%
CEO tenure2yrs
CEO ownershipn/a
Management average tenure2.2yrs
Board average tenure6.7yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Bhushan Akshikar's remuneration changed compared to GlaxoSmithKline Pharmaceuticals's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

₹7b

Jun 30 2024n/an/a

₹6b

Mar 31 2024₹67m₹15m

₹6b

Dec 31 2023n/an/a

₹5b

Sep 30 2023n/an/a

₹6b

Jun 30 2023n/an/a

₹6b

Mar 31 2023₹34m₹4m

₹6b

Compensation vs Market: Bhushan's total compensation ($USD787.24K) is above average for companies of similar size in the Indian market ($USD589.68K).

Compensation vs Earnings: Bhushan's compensation has increased by more than 20% in the past year.

CEO

Bhushan Akshikar

2yrs

Tenure

₹66,885,000

Compensation

Mr. Bhushan Akshikar is Managing Director of GlaxoSmithKline Pharmaceuticals Limited from December 1, 2022. He served as Additional Director of GlaxoSmithKline Pharmaceuticals Limited since March 18, 2021...

Leadership Team

NamePositionTenureCompensationOwnership
Bhushan Akshikar
MD & Executive Director2yrs₹66.89mno data
Juby Chandy
Whole-Time Director & CFO2.7yrs₹68.92mno data
Chinmay Sharma
Executive Vice President of Human Resources4yrs₹37.40mno data
Aparajita Rajput
Vice President of Technologyless than a yearno datano data
Ajay Nadkarni
VP of Administration & Real Estate and Company Secretaryno data₹11.57mno data
Amit Pandey
Executive Vice President of Legal2.8yrsno datano data
Simrat Sohal
Vice President of Ethics & Compliance1.8yrsno datano data
Ransom D'Souza
Executive Vice President of Communications & Government Affairs7.7yrsno datano data
Sukanya Choudhary
Executive Vice-President of Regulatory Affairsno datano datano data
Shourov Mukherjee
Executive Vice-President of Adult Vaccines2.4yrsno datano data
Upendra Singh
Executive Vice President of General Medicines2yrsno datano data
Sharmishta Mitra
Commercial Head - Paediatric Vaccines1.9yrsno datano data

2.2yrs

Average Tenure

Experienced Management: 500660's management team is considered experienced (2.2 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Bhushan Akshikar
MD & Executive Directorno data₹66.89mno data
Juby Chandy
Whole-Time Director & CFO2.7yrs₹68.92mno data
Renu Karnad
Non-Executive Chairperson5.7yrs₹3.25mno data
Manu Anand
Independent Director2.6yrs₹2.65mno data
Damodarannair Sundaram
Non-Executive Independent Director15.4yrs₹2.70mno data
Subesh Williams
Non Executive Director7.7yrsno datano data
Pradeep Bhide
Non-Executive Independent Director14.2yrs₹2.70mno data
Anami Narayan Roy
Non-Executive Independent Director13.1yrs₹2.45mno data
Sunita Maheshwari
Non-Executive & Independent Director4.6yrs₹2.45mno data

6.7yrs

Average Tenure

68.5yo

Average Age

Experienced Board: 500660's board of directors are considered experienced (6.7 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 01:41
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

GlaxoSmithKline Pharmaceuticals Limited is covered by 25 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Shirish PardeshiAnand Rathi Shares and Stock Brokers Limited
Sarabjit NangraAngel Broking Private Limited
Prakash AgarwalAxis Capital Limited